Isabel M. Mountain

540 total citations
21 papers, 413 citations indexed

About

Isabel M. Mountain is a scholar working on Infectious Diseases, Animal Science and Zoology and Molecular Biology. According to data from OpenAlex, Isabel M. Mountain has authored 21 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Animal Science and Zoology and 4 papers in Molecular Biology. Recurrent topics in Isabel M. Mountain's work include Viral gastroenteritis research and epidemiology (6 papers), Animal Virus Infections Studies (4 papers) and Viral Infections and Immunology Research (4 papers). Isabel M. Mountain is often cited by papers focused on Viral gastroenteritis research and epidemiology (6 papers), Animal Virus Infections Studies (4 papers) and Viral Infections and Immunology Research (4 papers). Isabel M. Mountain collaborates with scholars based in United States. Isabel M. Mountain's co-authors include Hattie E. Alexander, Gebhard Koch, George S. Tarnowski, Christiane Stock, Katherine Sprunt, Hans Ulrich Weltzien, P. G. Munder, Otto Westphal, Robert Kassel and Dalton Wang and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Isabel M. Mountain

21 papers receiving 342 citations

Peers

Isabel M. Mountain
M Tonew Germany
M. Knight United Kingdom
H. G. duBuy United States
Henry Brzeski United Kingdom
S.C. Schultz United States
Thomas Hesson United States
W Phares United States
Paul Siminoff United States
M Tonew Germany
Isabel M. Mountain
Citations per year, relative to Isabel M. Mountain Isabel M. Mountain (= 1×) peers M Tonew

Countries citing papers authored by Isabel M. Mountain

Since Specialization
Citations

This map shows the geographic impact of Isabel M. Mountain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel M. Mountain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel M. Mountain more than expected).

Fields of papers citing papers by Isabel M. Mountain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel M. Mountain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel M. Mountain. The network helps show where Isabel M. Mountain may publish in the future.

Co-authorship network of co-authors of Isabel M. Mountain

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel M. Mountain. A scholar is included among the top collaborators of Isabel M. Mountain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel M. Mountain. Isabel M. Mountain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stock, Christiane, Daniel Martín, Kanematsu Sugiura, et al.. (1978). Antitumor tests of amygdalin in spontaneous animal tumor systems. Journal of Surgical Oncology. 10(2). 89–123. 16 indexed citations
2.
Anderson, Lucy M., et al.. (1978). 3-Hydroxyxanthine: Transplacental Effects and Ontogeny of Related Sulfate Metabolism in Rats and Mice<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 61(6). 1405–10. 3 indexed citations
3.
Tarnowski, George S., Isabel M. Mountain, Christiane Stock, et al.. (1978). Effect of lysolecithin and analogs on mouse ascites tumors.. PubMed. 38(2). 339–44. 44 indexed citations
4.
Teller, Morris N., Christiane Stock, LEON HELLMAN, et al.. (1977). Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.. PubMed. 37(11). 3932–8. 17 indexed citations
5.
Tarnowski, George S., Robert Kassel, Isabel M. Mountain, et al.. (1976). Comparison of antitumor activities of pancreatic ribonuclease and its cross-linked dimer.. PubMed. 36(11 Pt 1). 4074–8. 32 indexed citations
6.
Teller, Morris N., et al.. (1974). Influence of Age of Host on the Chemotherapy of Murine Myeloma LCP-1. Journal of Gerontology. 29(4). 360–365. 7 indexed citations
7.
Teller, Morris N., et al.. (1974). Combination Chemotherapy of Advanced Murine Myeloma and Subsequent Resistance to Tumor Cell Challenge 2. JNCI Journal of the National Cancer Institute. 52(3). 667–671. 2 indexed citations
8.
Tarnowski, George S., Isabel M. Mountain, & Christiane Stock. (1973). Influence of genotype of host on regression of solid and ascitic forms of sarcoma 180 and effect of chemotherapy on the solid form.. PubMed. 33(8). 1885–8. 13 indexed citations
9.
Tarnowski, George S., Isabel M. Mountain, & Christiane Stock. (1970). Combination therapy of animal tumors with L-asparaginase and antagonists of glutamine or glutamic acid.. PubMed. 30(4). 1118–22. 9 indexed citations
10.
Mountain, Isabel M., et al.. (1966). Chemotherapy studies in an animal tumor spectrum. 3. Evaluation of the toxicity differential index.. PubMed. 26(2). 258–64. 6 indexed citations
11.
Tarnowski, George S., et al.. (1965). Determination of acid-soluble thiols and disulfides in transplanted animal tumors. Archives of Biochemistry and Biophysics. 110(1). 210–216. 13 indexed citations
12.
Mountain, Isabel M. & Hattie E. Alexander. (1959). Infectivity of Ribonucleic Acid (RNA) from Type I Poliovirus in Embryonated Egg.. Experimental Biology and Medicine. 101(3). 527–532. 17 indexed citations
13.
Alexander, Hattie E., et al.. (1958). INFECTIVITY OF RIBONUCLEIC ACID FROM POLIOVIRUS IN HUMAN CELL MONOLAYERS. The Journal of Experimental Medicine. 108(4). 493–506. 110 indexed citations
14.
Alexander, Hattie E., et al.. (1958). Infectivity of ribonucleic acid of poliovirus on HeLa cell monolayers. Virology. 5(1). 172–173. 45 indexed citations
15.
Mountain, Isabel M.. (1955). Antibody production by spleen in vitro. II. Correlation of weight of rabbit, weight of spleen, and level of antibody produced in vitro.. PubMed. 74(4). 278–80. 4 indexed citations
16.
Mountain, Isabel M.. (1955). Antibody Production by Spleen In Vitro. The Journal of Immunology. 74(4). 270–277. 14 indexed citations
17.
Sprunt, Katherine, Isabel M. Mountain, Winifred Redman, & Hattie E. Alexander. (1955). Production of poliomyelitis virus with combined antigenic characteristics of type I and type II. Virology. 1(2). 236–249. 14 indexed citations
18.
Mountain, Isabel M.. (1955). Antibody production by spleen in vitro. I. Influence of cortisone and other chemicals.. PubMed. 74(4). 270–7. 20 indexed citations
19.
Mountain, Isabel M.. (1955). Production of Type Specific Antisera to Poliomyelitis Viruses in Rabbits.. Experimental Biology and Medicine. 90(1). 271–274. 4 indexed citations
20.
Mountain, Isabel M.. (1955). Cytopathogenic Effect of Antiserum to Human Malignant Epithelial Cells (Strain HeLa) on HeLa Cell Culture. The Journal of Immunology. 75(6). 478–484. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026